Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for reducing symptoms of multiple sclerosis using a six-amino acid long peptide that inhibits CD40-CD150 interaction

Methods for reducing symptoms of multiple sclerosis using a six-amino acid long peptide that inhibits CD40-CD150 interaction

US Patent 11793854 · Granted Oct 24, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for reducing symptoms of multiple sclerosis using a six-amino acid long 2025
Methods for reducing symptoms of multiple sclerosis using a six-amino acid long 2025
Methods for reducing symptoms of multiple sclerosis using a six-amino acid long 2025
Therapeutic peptides and methods for treating type 2 diabetes2025
Therapeutic peptides and methods for treating type 2 diabetes2025
Therapeutic peptides and methods for treating type 2 diabetes2025
Portable granular particle spreader2025
Peptides and methods for treating disease2025
Peptides and methods for treating disease2025
Peptides and methods for treating disease2025
Bioactive peptides and methods of use thereof2024
Bioactive peptides and methods of use thereof2024